Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_129e393582e6bdf4029baf2206522f45 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-215 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P27-02 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P27-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-21 |
filingDate |
1994-09-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8babb6827604ee20f0a4219a94a9e917 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_82ba00af1f9a3f985b9481212270c3a6 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8fd9bfb26d7c95f1e16330004d6184ab http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9add15b0e0dc68067dd7f778f621186a |
publicationDate |
1996-03-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
JP-H0881389-A |
titleOfInvention |
Retinal pigment epithelial cell proliferation agent |
abstract |
(57) [Summary] [Composition] A retinal pigment epithelial cell proliferation agent containing interferon as an active ingredient. [Effect] The retinal pigment epithelial cell proliferation agent containing the interferon of the present invention as an active ingredient can be used as a useful therapeutic agent for eye diseases such as retinal pigment degeneration, central reticulochoroidopathy, and macular dystrophy. |
isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6086869-A http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-9822129-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-9629092-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5948403-A |
priorityDate |
1994-09-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |